Characterization of mouse lymphoma cells with altered nucleoside transport.
A mutant clone (NT-1) of a T-cell lymphoma was selected for its ability to grow in HAT medium (hypoxanthine, aminopterin and thymidine) in the presence of the nucleoside transport inhibitor P-nitrobenzyl-6-mercaptoinosine (NBMI). NT-1 cells contain half the number of NBMI binding sites present on the parental S49 cells and are partially able to transport nucleosides in the presence of the transport inhibitor (NBMI). These observations suggest that the mutant cells are heterozygous for nucleoside transport proteins and contain two types of transport proteins: the first protein can both bind and is inhibited by NBMI similar to the wild type phenotype, and the second is an altered protein. The altered transport protein apparently lost its NBMI binding sites without a parallel loss of nucleoside transport ability suggesting that the nucleoside transported sites are separate from the binding sites of the transport inhibitor.
D000241:Adenosine / Q000378:metabolism; D000818:Animals; D001692:Biological Transport; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003841:Deoxycytidine / Q000378:metabolism; D007700:Kinetics; D008223:Lymphoma / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D009705:Nucleosides / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013868:Thioinosine / Q000031:analogs & derivatives / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism
D009705:Nucleosides; D003841:Deoxycytidine; D013868:Thioinosine; C001789:4-nitrobenzylthioinosine; D000241:Adenosine; D013936:Thymidine